80 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
product for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver … risks, including intellectual property, regulatory laws, local laws, tax and accounting. To finance any acquisitions or asset purchase, we may choose
8-K
EX-99.1
a22c1k13oz98 n4
21 Mar 24
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
7:31am
8-K
EX-1.1
v94vc3tydxw3x l74q47
28 Feb 24
Absci Announces Proposed Public Offering of Common Stock
4:06pm
424B5
1n4mceda
28 Feb 24
Prospectus supplement for primary offering
8:34am
424B5
77vrdxxzkvg89az
27 Feb 24
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
gaxs797qw8v0atta08o2
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
8-K
EX-99.1
ry5hb00 2p7ivt
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
424B5
j5yamkl
16 Jun 23
Prospectus supplement for primary offering
4:45pm
8-K
EX-1.1
k91mjboxth
16 Jun 23
Entry into a Material Definitive Agreement
4:23pm